Ignite Creation Date:
2024-05-06 @ 9:26 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02988817
Status:
COMPLETED
Last Update Posted:
2023-08-01
First Post:
2016-12-01
Brief Title:
Enapotamab Vedotin HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
Sponsor:
Genmab
Organization:
Genmab
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-23
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-01
First Submit QC Date:
December 8 2016
Study First Post Date:
2016-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-01-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-31
Last Update Post Date:
2023-08-01
Last Update Post Date Type:
ACTUAL